Impact of duration of chronic migraine on long-term effectiveness of monoclonal antibodies targeting the calcitonin gene-related peptide pathway-A real-world study.
Raffaele OrnelloFrancesca BaldiniAgnese OnofriChiara RosignoliFederico De SantisAndrea BurgalassiAlberto ChiarugiPierangelo GeppettiSimona SaccoLuigi Francesco IannonePublished in: Headache (2024)
Our data showed that anti-CGRP mAbs are effective and have a rapid onset of action in CM regardless of disease duration.